Early Staged Consent Before Prostate Biopsy
Primary Purpose
Prostate Cancer
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Meditation
Prostate Biopsy
Questionnaires
Sponsored by

About this trial
This is an interventional supportive care trial for Prostate Cancer focused on measuring mind-body intervention, 18-189
Eligibility Criteria
Inclusion Criteria:
- All male patients that will be scheduled for standard prostate needle biopsy (first, repeat or active surveillance biopsy) under local anesthesia and potentially consented to the mindfulness study of mind-body intervention for prostate biopsy within the next 12 months.
- English fluent
Exclusion Criteria:
- Patient with prior rectal surgery or anal stricture requiring surgical intervention prior to biopsy.
- Prior prostate radiation
Sites / Locations
- Memorial Sloan Kettering Cancer Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Usual Care + Meditation
Usual Care Group
Arm Description
Usual care (local anaesthesia) + audio-recorded brief mind-dody intervention for 10 minutes before and for 10 minutes during the prostate biopsy procedure
Time-and-attention control group receiving usual care (local anesthesia) including optional background music in the biopsy procedure room
Outcomes
Primary Outcome Measures
number of patients who sign consent form
Secondary Outcome Measures
Full Information
NCT ID
NCT03507725
First Posted
April 15, 2018
Last Updated
June 30, 2023
Sponsor
Memorial Sloan Kettering Cancer Center
1. Study Identification
Unique Protocol Identification Number
NCT03507725
Brief Title
Early Staged Consent Before Prostate Biopsy
Official Title
Improving Patient Experience and Outcomes for Men Undergoing Prostate Biopsy: A Randomized Controlled Trial With Early Stage Consent
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 11, 2018 (Actual)
Primary Completion Date
April 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Memorial Sloan Kettering Cancer Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
This is a study and a novel approach to clinical trials, testing the feasibility and acceptability of two-stage consent in the context of a trial integrated into routine clinical practice. The investigator will use, as a model, a trial of a brief mind-body intervention) with guided imagery for procedural pain at the time of prostate biopsy. In the two-stage design, patients will first be approached for consent to 1) have their routinely collected clinical data used for research purposes and 2) be randomly selected to be offered an intervention to improve the experience of prostate biopsy. Only patients randomized to the experimental arm will be informed about the benefits and harms of the intervention and will sign a second consent for the experimental treatment. There will be two separate randomizations in this study, one-stage (usual informed consent) vs. two-stage consent and mindfulness intervention vs. control.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer
Keywords
mind-body intervention, 18-189
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
390 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual Care + Meditation
Arm Type
Experimental
Arm Description
Usual care (local anaesthesia) + audio-recorded brief mind-dody intervention for 10 minutes before and for 10 minutes during the prostate biopsy procedure
Arm Title
Usual Care Group
Arm Type
Active Comparator
Arm Description
Time-and-attention control group receiving usual care (local anesthesia) including optional background music in the biopsy procedure room
Intervention Type
Behavioral
Intervention Name(s)
Meditation
Intervention Description
The brief mind-body intervention, specifically developed for this study, is a combination of "mindfulness meditation" with a specific cognitive component of "guided imagery". Patient intervention, they will be given headphones connected to an MP4 player in the clinic area to listen to a pre-biopsy mindfulness exercise (10 minutes). They will then be brought into the biopsy procedure room and given a second set of headphones, guiding the patient through the mindfulness intervention during the biopsy procedure (10 minutes).
Intervention Type
Procedure
Intervention Name(s)
Prostate Biopsy
Intervention Description
Prostate needle biopsy under local anesthesia
Intervention Type
Behavioral
Intervention Name(s)
Questionnaires
Intervention Description
Questionnaires completion will be by telephone interview or manual completion of paper or online REDCap instruments, depending on participant preference.
Primary Outcome Measure Information:
Title
number of patients who sign consent form
Time Frame
2 years
10. Eligibility
Sex
Male
Gender Based
Yes
Gender Eligibility Description
Prostate Cancer
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All male patients that will be scheduled for standard prostate needle biopsy (first, repeat or active surveillance biopsy) under local anesthesia and potentially consented to the mindfulness study of mind-body intervention for prostate biopsy within the next 12 months.
English fluent
Exclusion Criteria:
Patient with prior rectal surgery or anal stricture requiring surgical intervention prior to biopsy.
Prior prostate radiation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Behrar Ehdaie, MD, MPH
Organizational Affiliation
Memorial Sloan Kettering Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Memorial Sloan Kettering Cancer Center
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States
12. IPD Sharing Statement
Links:
URL
http://www.mskcc.org/mskcc/html/44.cfm
Description
Memorial Sloan Kettering Cancer Center
Learn more about this trial
Early Staged Consent Before Prostate Biopsy
We'll reach out to this number within 24 hrs